STAT3 and cancer: Also, in line with our observations in human PBMCs, tumor-derived factors in conditioned media from tumor cells with elevated STAT3 activity have been shown to promote cancer immunosuppression through dendritic cell maturation and activation inhibition, as well as interfering with leukocyte migration (59–61).